Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

February 26, 2024

Study Completion Date

May 31, 2024

Conditions
Pancreas CancerDiagnosis
Interventions
DEVICE

Purine metabolite (Hypoxanthine, Xanthine) in urine by CubeBio

"* Collect urine from the patient to measure urinary hypoxia, xanthine concentration.~* Hypoxic acid, xanthine analysis in urine using High Performance Liquid Chromatography (HPLC).~* After that, hypoxanthine and xanthine will be analyzed using purine metabolite analysis reagents.~* Compare the cutoff of the metabolic value of Pancreas cancer clarified in the existing research and the value of the sample."

Trial Locations (1)

Unknown

RECRUITING

Ho-Seong Han, Seongnam-si

All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

lead

Ho-Seong Han

OTHER